To main content To main navigation

Ed Schuuring

Professor and clinical scientist in molecular pathology (KMBP) Profile

Professor and clinical scientist in molecular pathology (KMBP)

Contact information

Discover our research

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries

2024, The Lancet Regional Health - Europe

Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer

2024, The Lancet Regional Health - Europe

All publications

- “Circulating tumor DNA as an early on-treatment predictive biomarker for patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors”Ed Schuuring (Invited speaker) 6-Dec-2021 → 7-Dec-2021 Academic presentation > Academic
- ”Summary of survey questions: efforts for harmonization by Dutch COIN consortium”Ed Schuuring (Invited speaker) 6-Dec-2021 Academic presentation > Academic
- ”ALK mutatieanalyse met behandelconsequentie”Ed Schuuring (Invited speaker) 18-Nov-2021 → 19-Nov-2021 Academic presentation > Academic
- “Circulating tumor DNA as an early on-treatment predictive biomarker for patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors”Ed Schuuring (Invited speaker) 9-Nov-2021 → 11-Nov-2021 Academic presentation > Academic
- “Circulating tumor DNA as a monitoring tool for clinical outcome in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors”Ed Schuuring (Invited speaker), Ed Schuuring (Contributor) 4-Nov-2021 → 5-Nov-2021 Academic presentation > Academic
All activities
- Positive Droplet Award for to Liquid Biopsy and advancement of digital PCR (Bio-RAD)Ed Schuuring, 2021 Academic
All prizes

Contact